Search
Categories
Hot topics close

Lower price for MS drug paves the way for positive recommendation from NICE

Lower price for MS drug paves the way for positive recommendation from NICE
In its final draft guidance published today (9 May 2019), NICE has reversed its previous draft decision not to recommend ocrelizumab (Ocrevus, Roche) for treating primary progressive multiple sclerosis (PPMS) in adults. This follows an agreement between".
Similar news
News Archive
  • Mumford and Sons
    Mumford and Sons
    Mumford & Sons' Winston Marshall quits to avoid 'self-censorship'
    25 Jun 2021
    1
  • Get Out
    Get Out
    Us vs Get Out: Which Jordan Peele Movie Is Scarier?
    12 Oct 2023
    16
  • NYSEAXTA
    NYSE:AXTA
    Global Waterborne UV Coating Systems Market Strategics Assessment 2019 – 2023 : Bayers MaterialScience, Axalta ...
    15 Nov 2019
    1
  • Elle Darby
    Elle Darby
    Influencer Elle Darby apologises over racist tweets
    3 Jan 2022
    7
  • Holly Holm
    Holly Holm
    UFC Vegas 55: Holm Vs. Vieira - Results
    22 May 2022
    9
  • Tom Pidcock
    Tom Pidcock
    Tom Pidcock admits to being 'mentally frazzled' by transfer speculation
    3 Aug 2024
    5
This week's most popular news